InvestorsHub Logo
Followers 0
Posts 30
Boards Moderated 0
Alias Born 09/26/2017

Re: Value_Investor post# 2424

Friday, 05/25/2018 9:06:10 AM

Friday, May 25, 2018 9:06:10 AM

Post# of 2495
My confidence is still high considering Dr. Christopher Henney as the Chairman of BOD. Pretty sure he led the recent acquisition of Cascadian Therapeutics (formerly Oncothyreon)of which also the chairman of bod, by Seattle Genetics. He is also a director at Cyclacel Pharmaceuticals (CYCC).

GL